Terms: = Pancreatic cancer AND MAP2K4, MEK4, 6416, P45985, ENSG00000065559, SERK1, JNKK1, MKK4, PRKMK4, MAPKK4, JNKK, SEK1 AND Prognosis
4 results:
1. A new prognosis prediction model combining TNM stage with map2k4 and JNK in postoperative pancreatic cancer patients.
Liu XD; Zhang ZW; Wu HW; Liang ZY
Pathol Res Pract; 2021 Jan; 217():153313. PubMed ID: 33341545
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological and prognostic significance of mkk4 and MKK7 in resectable pancreatic ductal adenocarcinoma.
Lu J; Zhou L; Yang G; Liang ZY; Zhou WX; You L; Yuan D; Li BQ; Guo JC; Zhao YP
Hum Pathol; 2019 Apr; 86():143-154. PubMed ID: 30537492
[TBL] [Abstract] [Full Text] [Related]
3. map2k4/mkk4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course.
Xin W; Yun KJ; Ricci F; Zahurak M; Qiu W; Su GH; Yeo CJ; Hruban RH; Kern SE; Iacobuzio-Donahue CA
Clin Cancer Res; 2004 Dec; 10(24):8516-20. PubMed ID: 15623633
[TBL] [Abstract] [Full Text] [Related]
4. Progress in cancer genetics: lessons from pancreatic cancer.
Goggins M; Kern SE; Offerhaus JA; Hruban RH
Ann Oncol; 1999; 10 Suppl 4():4-8. PubMed ID: 10436774
[TBL] [Abstract] [Full Text] [Related]
